Literature DB >> 8103286

Clinical and molecular analyses of deletion 3p25-pter syndrome.

P N Mowrey1, M J Chorney, C P Venditti, F Latif, W S Modi, M I Lerman, B Zbar, D B Robins, P K Rogan, R L Ladda.   

Abstract

Hemizygous deletion of 3p25-pter is associated with a phenotype of profound growth failure, microcephaly, characteristic facial changes, and mental retardation. Since the severity may be quite variable, we have studied 3 cases of del 3p25-pter to define the clinical manifestations and the critical chromosome region for phenotypic expression. The patient we now report died at age 6 months and provided an opportunity for a detailed necropsy analysis for only the second time in a del(3p) patient. He had marked hypoplasia of all organs, hypomyelination of white matter, and multiple renal cortical microcysts. Ordered genomic markers from the distal regions of chromosome 3p aided in determining the parent of origin of each deletion and in defining the boundaries of the deleted chromosomal segments. The deleted markers distal to the RAF1 oncogene in 2 of the 3 patients were consistently hemizygous. One patient had an interstitial deletion based on evidence of diploid inheritance of one of the most distal loci (D3S17). Available genetic linkage maps suggest that the deletion spans at least 19 centimorgans (cM).

Entities:  

Mesh:

Year:  1993        PMID: 8103286     DOI: 10.1002/ajmg.1320460604

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

Review 1.  A novel case of unilateral blepharophimosis syndrome and mental retardation associated with de novo trisomy for chromosome 3q.

Authors:  T Cai; D A Tagle; X Xia; P Yu; X X He; L Y Li; J H Xia
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  Precise localisation of 3p25 breakpoints in four patients with the 3p-syndrome.

Authors:  T Drumheller; B C McGillivray; D Behrner; P MacLeod; D E McFadden; J Roberson; C Venditti; K Chorney; M Chorney; D I Smith
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

Review 3.  Rho-linked genes and neurological disorders.

Authors:  Nael Nadif Kasri; Linda Van Aelst
Journal:  Pflugers Arch       Date:  2007-11-15       Impact factor: 3.657

4.  46,XX, inv(6)(p21.1p23) in a pedigree with hereditary haemochromatosis.

Authors:  C P Venditti; N K Seese; G S Gerhard; A E Ten Elshof; K A Chorney; P N Mowrey; P G Lacey; J H Knoll; M J Chorney
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

5.  Detailed mapping of a congenital heart disease gene in chromosome 3p25.

Authors:  E K Green; M D Priestley; J Waters; C Maliszewska; F Latif; E R Maher
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

6.  Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.

Authors:  Thomas Fernandez; Thomas Morgan; Nicole Davis; Ami Klin; Ashley Morris; Anita Farhi; Richard P Lifton; Matthew W State
Journal:  Am J Hum Genet       Date:  2004-04-21       Impact factor: 11.025

7.  Cytogenetic findings indicate heterogeneity in patients with blepharophimosis, epicanthus inversus, and developmental delay.

Authors:  M Warburg; M Bugge; K Brøndum-Nielsen
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

8.  Agenesis and dysgenesis of the corpus callosum: clinical, genetic and neuroimaging findings in a series of 41 patients.

Authors:  Chayim Can Schell-Apacik; Kristina Wagner; Moritz Bihler; Birgit Ertl-Wagner; Uwe Heinrich; Eva Klopocki; Vera M Kalscheuer; Maximilian Muenke; Hubertus von Voss
Journal:  Am J Med Genet A       Date:  2008-10-01       Impact factor: 2.802

9.  A 3.1-Mb microdeletion of 3p21.31 associated with cortical blindness, cleft lip, CNS abnormalities, and developmental delay.

Authors:  Chad R Haldeman-Englert; Xiaowu Gai; Juan Carlos Perin; Melissa Ciano; Sara S Halbach; Elizabeth A Geiger; Donna M McDonald-McGinn; Hakon Hakonarson; Elaine H Zackai; Tamim H Shaikh
Journal:  Eur J Med Genet       Date:  2008-12-13       Impact factor: 2.708

Review 10.  Taurine and its chloramine: modulators of immunity.

Authors:  Georgia B Schuller-Levis; Eunkyue Park
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.